Literature DB >> 1996583

Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training.

B J Fahey1, D E Koziol, S M Banks, D K Henderson.   

Abstract

PURPOSE: During annual periods before and after Universal Precautions training, we compared the frequency of health care workers' self-reported cutaneous exposures to blood and various body substances from any patient and from patients presumed infected with human immunodeficiency virus type 1 (HIV-1). SUBJECTS AND METHODS: Self-reported cutaneous exposures to blood, sputum, urine, feces, and other body substances were evaluated separately in 559 workers during the first survey and 269 workers during the second.
RESULTS: Mean annual blood exposures decreased from 35.8 to 18.1, and mean annual exposures to all substances decreased from 77.8 to 40.0 (p less than 0.001 for both determinations). Two matched analyses of a subset of 200 participants who completed both surveys had similar results. Reported exposures to blood, presumably infectious blood, sputum, presumably infectious sputum, and urine were significantly decreased. Participants were tested for antibodies to HIV-1; no participant reporting cutaneous exposures acquired HIV-1 infection. The upper bound for the 95% confidence interval for the risk of HIV-1 infection associated with a single cutaneous exposure was 0.04% for blood presumed to contain HIV-1 and 0.02% for any body substance presumed to contain HIV-1.
CONCLUSIONS: These data suggest that Universal Precautions training significantly decreased but did not eliminate cutaneous exposures to blood and body substances. The results further suggest that the risk for HIV-1 infection associated with cutaneous exposures is substantially lower than the risk associated with parenteral exposures.

Entities:  

Mesh:

Year:  1991        PMID: 1996583

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Universal precautions--do Irish anaesthetists comply?

Authors:  N O'Rourke; M Bennett; J Porter; D J Gallagher; G Shorten
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 1.568

2.  Infections Associated with Health-care Personnel: Vaccine-preventable Diseases and Bloodborne Pathogens.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

Review 3.  Post-exposure prophylaxis for blood borne viral infections in healthcare workers.

Authors:  G M Varghese; O C Abraham; D Mathai
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401

4.  The protective efficacy of surgical latex gloves against the risk of skin contamination: how well are the operators protected?

Authors:  R V Hentz; G C Traina; R Cadossi; P Zucchini; M A Muglia; M Giordani
Journal:  J Mater Sci Mater Med       Date:  2000-12       Impact factor: 3.896

5.  Knowledge of post-exposure prophylaxis inadequate despite published guidelines.

Authors:  J Parra-Ruiz; L Muñoz-Medina; J Callejas-Rubio; M Martínez; M A Martínez-Pérez; J Hernández-Quero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

Review 6.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 7.  Human immunodeficiency virus and hepatitis--implications for operating room personnel.

Authors:  S Colbert; G J Sheehan
Journal:  Ir J Med Sci       Date:  1995-01       Impact factor: 1.568

Review 8.  Laboratory-associated infections and biosafety.

Authors:  D L Sewell
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 9.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 10.  Standard precautions and post exposure prophylaxis for preventing infections.

Authors:  M R Sridhar; S Boopathi; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2004-07       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.